SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-033856
Filing Date
2023-03-17
Accepted
2023-03-17 16:11:03
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm239873d1_4.html 4  
1 OWNERSHIP DOCUMENT tm239873d1_4.xml 4 5603
  Complete submission text file 0001104659-23-033856.txt   7213
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 213 SMITHFIELD ST PITTSBURGH PA 15222
Business Address
Stephan Dietrich A (Reporting) CIK: 0001774588 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 23742660